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Mutations in the mitochondrial helicase Twinkle underlie autosomal dominant progressive external ophthal-
moplegia (PEO), as well as recessively inherited infantile-onset spinocerebellar ataxia and rare forms of mito-
chondrial DNA (mtDNA) depletion syndrome. Familial PEO is typically associated with the occurrence of
multiple mtDNA deletions, but the mechanism by which Twinkle dysfunction induces deletion formation
has been under debate. Here we looked at the effects of Twinkle adPEO mutations in human cell culture
and studied the mtDNA replication in the Deletor mouse model, which expresses a dominant PEO mutation
in Twinkle and accumulates multiple mtDNA deletions during life. We show that expression of dominant
Twinkle mutations results in the accumulation of mtDNA replication intermediates in cell culture. This indi-
cated severe replication pausing or stalling and caused mtDNA depletion. A strongly enhanced accumulation
of replication intermediates was evident also in six-week-old Deletor mice compared with wild-type litter-
mates, even though mtDNA deletions accumulate in a late-onset fashion in this model. In addition, our results
in cell culture pointed to a problem of transcription that preceded the mtDNA depletion phenotype and might
be of relevance in adPEO pathophysiology. Finally, in vitro assays showed functional defects in the various
Twinkle mutants and broadly agreed with the cell culture phenotypes such as the level of mtDNA depletion
and the level of accumulation of replication intermediates. On the basis of our results we suggest that mtDNA
replication pausing or stalling is the common consequence of Twinkle PEO mutations that predisposes to
multiple deletion formation.
INTRODUCTION
Mitochondrial diseases manifest with a broad spectrum of
symptoms but frequently involve skeletal muscle and/or the
nervous system. Diseases with mitochondrial DNA (mtDNA)
mutations are quite frequent, with prevalences of 1:11 000
in North-Eastern England (1) and 1:6000 for a single-point
mutation A3243G in Finland (2). mtDNA disease can be
split into two groups. A ﬁrst group comprises diseases
caused by primary mtDNA mutations that lead to impairment
of respiratory function. A second group is often referred to as
mtDNA maintenance diseases, as the underlying cause is a
dysfunction of the replication and maintenance machinery of
mtDNA, encoded by nuclear genes, that leads to a secondary
loss or damage of the mitochondrial genome and subsequent
mitochondrial dysfunction. These disorders have also been
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cies for single mutations reaching 1:100 in some populations
(3,4). The most severe examples of mtDNA maintenance dys-
function are early-onset, recessively inherited syndromes
characterized by severe mtDNA depletion in one or more
tissues, such as the Alpers-Huttenlocher syndrome associated
with mutations in the mtDNA polymerase gamma catalytic
subunit POLG1 (5,6). In contrast, autosomal progressive
external ophthalmoplegia (PEO) is late-onset form of
mtDNA maintenance disease. It affects mainly the function
of skeletal muscles, initiating with weakness of the
extra-ocular muscles during adulthood. Patients with autoso-
mal PEO do not typically show loss of mtDNA in tissues ana-
lyzed (7–9). Instead, large deletions of mtDNA accumulate in
post-mitotic tissues over time and the appearance of a con-
siderable amount of deletions is associated with the onset
and progression of symptoms (9).
Several essential proteins for mtDNA maintenance have
been described and characterized. The mitochondrial polymer-
ase gamma (PolG) functions as a heterotrimer consisting of a
catalytic alpha and two accessory beta subunits in mammals
(10,11). Polymerase gamma is assumed to be the replicative
polymerase in mitochondria. Mutations in the alpha subunit
cause mtDNA depletion syndromes (MDS) like Alpers-
Huttenlocher, SANDO (sensory-atactic neuropathy, dysarthria
and ophthalmoplegia) or MIRAS (mitochondrial recessive
ataxia syndrome) (3,12), but are also associated with recessive
and sporadic forms of PEO (13–15). Only one mutation of the
beta subunit associated with PEO has been described to date
(16). Twinkle, a hexameric DNA helicase of the RecA super-
family (17,18), is thought to be the replicative helicase of
mtDNA, as it functions together with PolG and single-stranded
DNA binding protein (mtSSB) in a minimal mtDNA repli-
some (19), while catalytic mutations or RNAi cause mtDNA
depletion (20–22) in human and insect cell culture. To date
and to our knowledge, 23 mutations in the Twinkle gene
(PEO1) have been shown to be associated with PEO, and
PEO1 mutations were recently shown to be the most prevalent
cause of adPEO in Italy (18,23). A single recessive mutation
(Y508C) has been uniquely identiﬁed in Finland and associ-
ates with infantile onset spinocerebellar ataxia. The same
mutation was recently identiﬁed in a compound heterozygous
conﬁguration with a A318T mutation in two siblings with a
severe MDS (24). A second recessive T457I mutation was
identiﬁed homozygous in a family with MDS (25).
While MDS might be caused by a complete impairment of
replication due to a non-functional component of the replica-
tion machinery, the precise molecular mechanism(s) for the
creation and slow accumulation of mtDNA deletions in PEO
is unknown. The Deletor mice, expressing an adPEO mutation,
a 13 amino acid duplication in the Twinkle linker region
equivalent to human amino acid 352–364, accumulate sub-
stantial amounts of mtDNA deletions in the skeletal muscle
and show similar histological features as the human patients,
but are functionally only mildly affected (26). This mouse
clearly proves that impaired Twinkle function is the under-
lying cause of mtDNA deletions and respiratory chain dys-
function and provides an excellent tool to study disease
progression. However, studies focusing in the actual molecular
mechanism of mtDNA deletion formation is hindered by the
fact that the deletions accumulate only slowly in vivo.
In this study, we therefore used cultured human cells to
study the effects of different Twinkle PEO mutations on
mtDNA replication. We show that PEO mutations impair
the helicase activity of Twinkle and lead to mtDNA replic-
ation stalling or pausing and reduced mitochondrial transcript
levels. Similarly, already in young Deletor mouse tissues,
we observed accumulation of replication intermediates,
indicative of pausing. Since mtDNA deletions in the
Deletor model accumulate only in a late-onset fashion, this
could suggest that early problems in mtDNA replication
predispose to the accumulation of deletions later in life.
We hypothesize that the accumulation of replication inter-
mediates can mediate an enhanced formation of mtDNA
deletions allowing for their later accumulation in adult
tissues in PEO patients.
RESULTS
Expression of dominant Twinkle PEO mutations
in proliferating cells leads to mtDNA depletion
In order to study the effect of Twinkle mutations found in
patients suffering from adPEO in a reduced cell model, we
established stable HEK293 Flp-InTM T-RExTM cell lines
expressing human Twinkle variants containing a C-terminal
Myc-His tag. This system has the advantage of allowing con-
trollable expression of transgenes in a proliferating human cell
background, and as the endogenous Twinkle gene is unaf-
fected, resembles under conditions of low induction, the
heterozygous situation in patients with PEO (22).
Seven adPEO-related mutations of Twinkle causing mild to
severe symptoms were chosen, including several mutations in
the linker region of Twinkle (dup352–364, A359T, S369P,
R374Q), two mutations located in the N-terminal domain in
close proximity to the linker region (W315L, K319E) and
one mutation in the helicase domain (W474C) (see Fig. 1A
for an overview). All mutations showed expression levels
comparable to transgenic wild-type Twinkle-Myc-His, and
overexpression could be modulated in a range from 1- to
20-fold over the endogenous wild-type Twinkle (Fig. 1B,
and not shown). Overexpression of wild-type Twinkle resulted
in a slight but statistically signiﬁcant copy-number increase, as
previously observed (22). In contrast, depletion of mtDNA
levels was observed after expression of all adPEO mutations
after thee days (Fig. 2A). The level of depletion depended
on the mutation. The point mutations K319E located at the
end of the N-terminal domain as well as the R374Q mutation
in the linker region reduced mtDNA levels to 25% within three
days, indicating the complete absence of successful replica-
tion. Expression of the 13 amino acid duplication within the
linker region also depleted mtDNA levels more than half,
while the remaining mutants caused a less severe drop of
mtDNA copy-number to 60–76%. None of the mutants
caused an increase of mtDNA copy-number when expressed
for several days, but for the milder mutations S369P and
A359T an initial increase in mtDNA levels after one to two
days of expression could sometimes be observed.
Interestingly, mtDNA transcript levels were also affected by
Twinkle mutations (Fig. 2B). After two days of overexpression,
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transcripts were strongly reduced. The reduction of H-strand
transcripts was stronger than the observed mtDNA copy-
number depletion after two days of expression (Fig. 2A),
indicating that the negative effect of Twinkle dysfunction on
transcription precedes the depletion of mtDNA and is not
due to reduced mtDNA template levels. The reduction in mito-
chondrial transcript levels appeared to cause a deﬁciency of
mitochondrial respiration indicated by increased acidiﬁcation
of the cell culture medium (not shown).
adPEO mutations affect nucleoid structure
ThemtDNAnucleoidsincellsoverexpressingTwinklevariants
for three days were visualized using immunocytochemistry
against DNA and the Twinkle protein tag. Twinkle wild-type
and W315L (Fig. 3 and Supplementary Material, Fig. S2)
co-localized with mtDNA in a pattern of small punctate struc-
tures that we have previously found to constitute mtDNA
nucleoids (27). The Twinkle variants K319E, R374Q and
dup352–364, and A359T to a lesser extent, showed a more
uniform mitochondrial matrix staining, but clearly also
nucleoid-like spots based on their co-localization with
mtDNA. The nucleoids in the K319E, R374Q, W474C and
dup352–364 expressing cell lines appeared larger in size and
fewer in number compared with wild-type. Finally, the S369P
mutation co-localized well with mtDNA similar to W315L.
Based on the mtDNA antibody, the number of mtDNA foci
seemed normal in cells overexpressing W315L and A359T or
even increased for S369P. All the other mutations lead to a
reduced number of spots, which could be expected from the
copy-number determination of these mutants. Based on
the observed effects we have categorized the severity of the
nucleoid phenotype as mild for mutants showing no or a
Figure 2. Mutant expression causes rapid mtDNA copynumber and transcript
level depletion. (A) While overexpression of wild-type Twinkle transiently
increased the relative copynumber of mtDNA per cell, expression of adPEO
variants lead to rapid mtDNA depletion. The loss of mtDNA correlated
approximately with the severity of the biochemical and replication defects
measured in this study. MtDNA levels of cells induced with 3 ng/ml doxycy-
cline for two days (grey bars) or three days (black bars) were quantiﬁed by
duplex Taqman PCR and normalized to non-induced cells of the same cell
line. Four to six independently isolated samples were measured in triplicate
with the exception of the two samples indicated with an asterisk that were iso-
lated twice and measured in triplicate. Similar results were obtained by
Southern blot analysis (not shown). Error bars show the standard deviation.
(B) Also the steady-state levels of mtDNA transcripts were decreased upon
Twinkle mutant expression, while the overexpression of wild-type Twinkle
and the resulting mtDNA increase did not change transcript levels. RNA
from cells grown for two days with or without 3 ng/ml DC was analysed by
Northen blot using probes against several mitochondrial transcripts as indi-
cated and 18S rRNA. Note that the decrease in transcripts occurred in
advance of mtDNA depletion (Fig. 2A). No effect on protein levels of repre-
sentative, nuclear encoded, respiration complex subunits were detected
by western blot analysis after 3 days (data not shown). Ldup refers to
dup352–364.
Figure 1. Expression of Twinkle adPEO mutations in HEK293 Flp-InTM
T-RExTM cells. (A) Schematic presentation of the human Twinkle protein
and localization of the adPEO-related mutations investigated in this study.
Most mutations are located at the end of the N-terminal domain or in the
linker region of Twinkle, only the W474C point mutation lies within the heli-
case domain. (B) Expression levels of adPEO Twinkle variants. Expression
was induced for three days with the indicated amounts of doxycycline (DC)
and protein expression was analyzed by western blot analysis against the myc-
tagged Twinkle variants. At 1 ng/ml DC no increase in transgene expression
could be observed, although mild effects on mtDNA replication were
already detectable (data not shown). Maximal expression was reached with
10 ng/ml DC.
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mtDNA immunoﬂuorescence (A359T, W315L, S369P), mod-
erate (K319E) and severe (R374Q, dup352–364, W474C)
and show one example each in Figure 3, A359T, K319E and
W474C respectively, while all mutants are shown in Sup-
plementary Material, Fig. S2. Particularly interesting is the
observation that especially for the Dup 352–364 and the
W474C one can observe a mosaic pattern of cells with some
cells being devoid entirely of the strong mtDNA positive foci,
whereas other cells of the same culture still showed nucleoid
structures. As the cell line used ensures single insertion of the
transgene in the genome and similar expression levels in all
cells studied, this variability in cell phenotypes could be indica-
tive of an mtDNA segregation defect.
Figure 3. Some adPEO Twinkle mutants alter the localization of the protein in mtDNA nucleoids. The subcellular localization of the Twinkle variants was
determined by immunoﬂuorescence. While wild-type Twinkle co-localized with mtDNA in punctate nucleoids within mitochondria, the disease variants
K319E Twinkle variants localized only partially with nucleoids, a proportion of the protein was diffusely localized in the mitochondrial lumen, while the
nucleoids often appeared enlarged (similar results were observed with the R374Q and dup 352–364 mutants; Supplementary Material, Fig. S2). The W474C
variant caused aggregation of nucleoids without a more diffuse distribution of the protein, while the A359T mutation decreased the Twinkle localization in
nucleoids without altering their size and number extensively. The effects of expression of the various mutants were categorized as mild, moderate and
severe as indicated in the Figure. Cells were induced with 3 ng/ml doxycycline for 3 days, immunocytochemistry was performed using speciﬁc antibodies
against the myc-tagged Twinkle variants (green) and DNA (red). Images were taken with the same settings for exposure, laser intensity, etc. and in addition
were processed for brightness and contrast in the same manner. All mutants are shown in Supplementary Material, Fig. S2.
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For in vitro assays, wild-type and mutant variants of Twinkle
were puriﬁed from crude mitochondrial fractions with a single-
step procedure using TALONw Co
2þ afﬁnity resin (see also
MaterialsandMethods).TALONafﬁnityresineluateswererou-
tinely checked using Coomassie staining (Supplementary
Material, Fig. S1), and showed a high level of puriﬁcation of
the Twinkle protein using this single-step procedure. Speciﬁc
activity of the wild-type Twinkle protein (speciﬁed as the con-
centration of Twinkle that gives 50% unwinding activity at a
given substrate concentration) puriﬁed in this manner seems
very similar to that observed with enzyme puriﬁed using a bacu-
lovirus expression system (28,29), although a precise compari-
son is not possible since we have used less DNA substrate and
measured at 378Cc o m p a r e dw i t h3 2 8C used by Korhonen
et al. Using approximately 5-fold less M13 substrate we ﬁnd
50% unwinding activity with 25 fmol of puriﬁed Twinkle,
whereas Korhonen et al. reaches 50% unwinding activity at
1.2 pmol of puriﬁed Twinkle (28) and at slightly less than
half that concentration in a later publication that used an
improved protocol to purify the enzyme (29). Given that we
used less substrate, our puriﬁed Twinkle is ﬁve to ten times
more active which seems in very good agreement given that
we measure the activity at 378C and not at 328C. For each
repeat of the various in vitro assays, 2808C frozen aliquots
were ﬁrst re-analyzed by Coomassie staining to estimate the
protein concentration of each sample using BSA as a standard,
to ensure the same concentration of wild-type and mutant pro-
teins were being used.
Twinkle is a low-processive helicase in vitro and alone can
unwind only short stretches of up to 25 nucleotides. In our
hands, the highest activity is achieved when 3 mM UTP is used
as an energy source, but also ATP, GTP and dGTP can drive
the unwinding reaction. As the natural concentrations of these
nucleotides within mitochondria are not known, we measured
the helicase activity of the wild-type Twinkle and the various
mutants separately with all four nucleotides (Fig. 4A). All
mutants had reduced unwinding activity compared with the
wild-type protein. The helicase activity of K319E and R374Q
was reduced to ,20%with all nucleotides, consistent with the
strong depletion observed with these mutants in cell culture.
However, the Dup 352–364 mutant had 70% remaining heli-
caseactivity,when GTP was usedas an energysource. The rela-
tive helicase activity was considerably lower with dGTP and
UTP. The W315L and W474C mutations showed an 70%
reduction in helicase activity irrespective of the nucleotide
used. The S369P showed a considerable reduction in helicase
activity despite its mild effect on mtDNA copy-number. The
mutation with the smallest effect on mitochondrial copy-
number, A359T, also had near to normal helicase activities.
As the nucleotide concentration of 3 mM is saturating and
might conceal any alteration in nucleotide afﬁnity in
Twinkle, we measured helicase activities of some mutations
with UTP, ATP and GTP over a broader range of nucleotide
concentrations. While the unwinding activity was reduced
gradually with reduced nucleotide concentrations, no mutant
showed a clear change in nucleotide kinetics (not shown).
The binding of Twinkle to single-stranded DNA in vitro
was evaluated by electromobility shift assay described
recently by Farge et al. (30). (Fig. 4B). The G575D mutation
affecting the DNA binding domain of Twinkle (22) was used
as a control and gave ,25% binding efﬁciency. Also the
adPEO mutations K319E, dup352–364 and W315L had
clearly reduced binding afﬁnities, while no clear effect was
seen with R374Q and A359T. As the only variant of those
investigated, the S369P mutation increased the afﬁnity to
ssDNA by 50% compared with wild-type.
ThemajorityofadPEOmutationsarelocatedclosetoorinthe
linker region of Twinkle. The homologous region in T7 was
Figure 4. AdPEO mutations affect the unwinding and ssDNA binding activity
of Twinkle. (A) Puriﬁed protein extracts of the various Twinkle mutations
showed clearly reduced maximal unwinding activity in in vitro assays using
an M13-based substrate. Most adPEO mutants had less than 25% remaining
unwinding activity with UTP, while dup352–364 and A359T were around
50% active compared with wild-type protein (P , 0.05 for dup 352–364
and A359T, P , 0.01 for all others). Other nucleotides (ATP, GTP and
dGTP) stimulated the unwinding activity of Twinkle to a lesser extend, but
were giving approximately similar decreases for the mutants, only A359T
exhibited full activity with ATP. (B) Twinkle ssDNA binding assays were per-
formed essentially as described previously (30) (see also Materials and
Methods). We used the G575D mutation previously described by us (22) as
an additional control as this mutation was expected to have clearly reduced
DNA afﬁnity and indeed showed very poor binding even compared with the
various adPEO Twinkle mutants. Of the adPEO mutants, K319E, dup352–
364 and W315L showed reduced binding, whereas R374Q and A359T
showed near normal ssDNA afﬁnity. The S369P in our hands showed a mod-
erately increased binding. Note that the W474C is not shown because this
protein with several repeated isolations gave spurious results. Binding is
expressed relative to the binding of the wild-type protein set at 100%.
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functional hexamer (31). Therefore, to investigate whether also
in Twinkle the reduction in helicase activity and DNA binding
are caused by impaired oligomerization, we analyzed the
multimeric state of Twinkle with isolated proteins in vitro
using a similar chromatographic approach, as described pre-
viously(29).AsalreadydescribedbyFargeetal.(30),wild-type
Twinkle forms hexamers even under high ionic-strength con-
ditions and in the absence of any nucleotide. Using similar
conditions, all proteins bearing adPEO mutations formed
hexamers, although differences in the degree of oligomerization
could readily be detected. Wild-type Twinkle, A359T, W474C,
W315L and S369P were mostly eluted at high molecular weight
in agreement with normal multimer stability (Fig. 5). The
R374Q, K319E and dup352–364 appeared less stable, but in
all three cases high molecular weight multimers could still be
detected. These results, as far as they involve the analysis of
the same mutations, are largely in agreement with Korhonen
et al. (29) (see Discussion). Similar results were obtained
using glutaraldehyde crosslinking (not shown).
Twinkle adPEO mutations cause mtDNA
replication stalling in cell culture
As we described earlier, structural mutations that abolish the
helicase activity of Twinkle affected replication of mtDNA
in cultured cells and led to strong replication stalling and the
accumulation of replication intermediates (22). To test
whether the reduced helicase activity of Twinkle adPEO
variants impaired mtDNA replication in a similar way, we
analyzed the mtDNA replication pattern of cultured cells
expressing wild-type and mutant Twinkle variants using two-
dimensional DNA gel electrophoresis (Fig. 6). The expression
of Myc-His-tagged wild-type Twinkle on top of the endogen-
ous Twinkle levels did not inﬂuence the replication pattern or
the abundance of replication intermediates except for one
species of molecules believed to be part of the termination
process in the non-coding region of mtDNA (22). In contrast,
a strong effect was visible when Twinkle K319E was
expressed in a similar fashion. Low expression levels of
Twinkle K319E lead to the appearance of a sharp double-
stranded bubble-arc in a fragment containing the non-coding
region of mtDNA, while the club-headed double bubble-arc
typical for RNA-rich initiation intermediates was reduced.
At the same time, the abundance of incompletely digested
intermediates containing RNA or single-stranded patches
was decreased. With higher expression levels these inter-
mediates vanished completely, with the y- and bubble-arc
remaining as the only visible features. This effect could be
observed also in other parts of the mitochondrial genome, indi-
cating a general problem with replication fork progression.
At full expression levels also the y-shaped intermediates
were decreased, indicating an accumulation of replicating
molecules shortly after initiation. This change resembled the
Figure 5. Some adPEO mutations decrease the stability of Twinkle hexamers. Gel ﬁltration chromatography of puriﬁed Twinkle proteins indicated the formation
of hexameric complexes in both wild-type and mutant proteins. The same results were obtained in the presence or absence of Mg
2þ ions and under salt conditions
from 100 to 500 mM NaCl (data not shown). The partial delay and the extensive trailing during the chromatography run indicated the relative instability of the
hexamers of K319E, R374Q and dup352–364. Following gel ﬁltration all collected fractions were concentrated and analyzed by western blot analysis as detailed
in Materials and Methods.
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Wanrooij et al. (22).
A similar although milder replication stalling was induced
when expressing R374Q, dup352–364 or W315L Twinkle
variants; while molecules on the y- and double-stranded
bubble-arc strongly accumulated, the levels of RNA-rich inter-
mediates decreased. Expression of the Twinkle S369P and
A359T mutations had the mildest effect, although also they
resulted in clear replication stalling and a shift to less RNA-
containing intermediates.
The W474C variant, the only helicase domain mutation
analyzed had a different effect: also here RNA-rich intermedi-
ates vanished and y-shaped molecules accumulated upon
expression, but in contrast to the previously described
mutants bubble-containing intermediates did not accumulate,
but vanished completely (Fig. 6 and Supplementary Material,
Fig. S3).
Transgenic animals expressing an adPEO Twinkle variant
show impaired replication already at young age
Although the replication stalling that is observed when expres-
sing Twinkle adPEO mutants in cell culture leads to rapid
loss of mtDNA, this effect has not been reported in adPEO
patients. To determine whether similar phenomena as in
cultured cells are found in vivo, we studied the mtDNA
Figure 6. MtDNA replication is stalling upon Twinkle mutant expression. 2DNAGE analysis of mtDNA replication intermediates from cells expressing Twinkle
variants for two to three days (2–3: two days of induction with 3 ng/ml doxycycline; 3–3: three days induction with 3 ng/ml doxycycline). 2DNAGE samples for
all panels consisted of puriﬁed mtDNA digested with HincII and probed with a radiolabeled cytochrome b gene fragment (nt 14 846–15 357). The detected
fragment includes the non-coding region of mtDNA, the cytochrome b, ND6, part of the ND5 gene and intervening tRNA genes (nt 13 636–1006). The
upper two panels show a comparison of mtDNA replication in non-induced and Twinkle wild-type overexpressing cells and the interpretation based on
earlier 2DNAGE analysis of mtDNA RIs (22). 1n, 3.9 kb non-replicating HincII fragment. b, bubble arcs. MtDNA bubble arcs are usually very sensitive to
RNase H due to the presence of patches of RNA–DNA especially on the lagging strand; therefore a second, degraded bubble arc is visible in cells incorporating
RNA into the lagging strand. y and y0 indicate ascending and descending parts of the y arc and (dy) indicates double-Y structures typical for the termination
region of replication. These will eventually form resolution intermediates resembling Holliday junctions (HJL-Holliday junction like molecules). Other
higher molecular weight fragments arise from the failure to cut RNA–DNA hybrids at a restriction site, these as well as the RNA-rich bubble arcs are
marked as RITOLS (RNA Incorporation ThroughOut the Lagging Strand). Overexpression of wild-type Twinkle did not change the replication pattern, the
only notable difference was a reproducible reduction in one of the HJL RIs as described earlier. In contrast the stronger disease mutations caused accumulation
of replication intermediates on the y- and bubble arc (y and b) and a decrease in all RITOLS related features. The milder disease mutations S359P and A369T had
only a moderately enhanced descending y-arc (y0) (note that the 1n spot in the A359T panel has run of the gel). The helicase domain mutation W474C was
exceptional as no bubble arc, indicating initiation in the non-coding region, was clearly visible, while similar to other strong mutants RITOLS had almost com-
pletely disappeared. This was even more clearly visible after induction with 10 ng/ml DC for three days as is illustrated in Supplementary Material, Fig. S3.
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ﬁrst histological signs of disease and detectable amounts of
mtDNA deletions appear at the age of 9–12 months. Simi-
larly, in Deletor brain, multiple mtDNA deletions as well as
depletion are becoming apparent after approximately one
year of age (26 and unpublished data). Since the number of
replicating mtDNA molecules is low in mice of old age, we
studied the heart, liver, skeletal muscle, kidney and brain of
animals of six weeks of age. The expression levels of the
transgenic mutant Twinkle compared with the endogenous
wild-type Twinkle mRNA were between 13 and 59% depend-
ing on the tissue. All these tissues at this age, including brain,
showed normal mtDNA copy-number levels. In contrast, the
analysis of replication patterns showed a striking accumulation
of replication intermediates in mutant animals in all tissues
examined except for liver. In the liver, the effect of transgene
expression on the accumulation of replication intermediates
was rather mild. Figure 7 shows the comparison for brain,
muscle, heart and liver mtDNA with the mutant transgene
expression level measured to be 39, 59, 45 and 16% of the
endogenous transcript level. The results for kidney (13% of
endogenous transcript level) were very similar to those
observed for brain (not shown). Similar results were obtained
for three different Deletor founder lines (26) (not shown),
demonstrating that the observed effect was not a consequence
of the transgene insertion sites. Also, transgenic overexpres-
sion of wild-type Twinkle at much higher levels (20) only
showed a slight quantitative change in replication inter-
mediates in all tissues (not shown) except in heart where
also qualitative changes were observed (Pohjoisma ¨ki et al.,
manuscript submitted) that were however not seen in the
Deletor mouse heart.
DISCUSSION
Mutations in the mtDNA helicase Twinkle are one of the
major causes of adPEO (18,23). Understanding how Twinkle
mutations cause mitochondrial dysfunction and multiple
mtDNA deletions in post-mitotic tissues in patients is one of
the primary goals in studying the effects of Twinkle mutants
using a combination of in vitro assays, cell culture and
animal models. Using these approaches we show here that
the Twinkle adPEO mutations cause a defect in mtDNA repli-
cation both in human cell culture and in a transgenic mouse
model (26), resulting in the accumulation of replication
intermediates, indicative of replication pausing/stalling. In
addition, we suggest that replication stalling can also result
in a mitochondrial transcription defect. Although the defects
of several of the mutations we studied are largely in agreement
with recent studies using both in vitro assays and insect cell
culture (21,29), we here extend these ﬁndings by studying
additional mutants in human cell culture, and show that the
cell culture ﬁndings are relevant for the disease pathogenesis,
as they can be replicated in vivo, in the Deletor mice.
Oligomerization
As Twinkle PEO is a dominantly inherited disease, the
mutations are heterozygous and the mutant protein coexists
with the wild-type protein. Therefore, adPEO Twinkle variants
are assumed to be dominant negative and to impair the func-
tion of wild-type Twinkle by interaction, which requires
co-hexamerization. We show here that the Twinkle mutants
K319E, dup352–364 and R374Q resulted in a moderate to
severe decrease of hexamer formation under all tested
Figure 7. Deletor mice expressing the mouse variant of dup352–364 Twinkle also show mtDNA replication stalling. 2DNAGE analysis of brain, skeletal
muscle, heart and liver mtDNA from young Deletor mice expressing the mouse Twinkle mutation equivalent to the human dup352–364 Twinkle variant
show, except for liver, a similar strong accumulation of replication intermediates on both y- and bubble arc as in cultured cells. MtDNA was isolated from
6-week-old transgenic mice and non-transgenic siblings and probed against the OH-containing ClaI fragment (nts 12086–634). A similar replication stalling
as observed in brain was also observed in kidney (data not shown).
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maintained. This is in apparent contrast with a recent study
(29) who found that several mutations including the R374Q
studied caused the helicase to be completely monomeric. In
seeming agreement with our results, the Drosophila R341Q
mutant, analogous to R374Q in humans, expressed and iso-
lated from Drosophila Schneider S2 cells retained the ability
to form multimers using glycerol-gradient sedimentation
(21), although the resolution of these experiments makes it
difﬁcult to assess to what extent hexamers were stable.
The apparent discrepancy of identical mutations showing
different multimerization abilities can be explained by the
different origin of the proteins in our study and that of Korho-
nen et al. (29). In the latter study, human Twinkle variants
were expressed in the cytosol of insect cells using baculovirus
which also ensures that the isolated mutant proteins are free
from any wild-type Twinkle. However, it was shown clearly
that co-expression with the wild-type form increased the
ability to form hexamers of otherwise monomeric mutant
protein, such as the R374Q mutant (29). In contrast, the pro-
teins used in our study are expressed in the mitochondria of
human cells that do contain functional wild-type Twinkle.
Although the mutant form is overexpressed to a great extent,
a small proportion of the extracted Twinkle hexamers does
contain one or more subunits of the wild-type Twinkle. This
might be especially the case for the R374Q variant that in
the studied cells was expressed at normal levels, but consist-
ently gave low yields when isolated. The diffuse mitochon-
drial signal in immunocytochemistry supports the possibility
of increased destabilization of this variant that might lead
to the selective puriﬁcation of heteromultimers containing
wild-type Twinkle. The same argument can be applied to the
expression of the R341Q Drosophila Twinkle protein (21),
as previously discussed (29). A second difference that might
apply to this discussion is that the localization of Twinkle
variants in mitochondria allows for potential post-translational
modiﬁcation that may inﬂuence and regulate the activity of
Twinkle in vivo. Mitochondrial chaperones that could assist
in protein stability and folding could also inﬂuence the
ability of mutants to form multimers. In conclusion, based
on the present and previous studies (21,29), the lost ability
of some of the mutant Twinkle PEO variants to form multi-
mers in their pure form does not reﬂect the in vivo ability of
the protein to interact with wild-type Twinkle, the situation
found in heterozygous PEO patients. Clearly, the presence of
wild-type Twinkle rescues a quarternary structural defect of
several mutant Twinkle variants to the extent that a heteromul-
timeric complex can be formed that is still able to perform its
function to some degree in mtDNA replication. The lost ability
to form homomultimers for some of the mutants does suggest
that either heteromultimer formation can be less efﬁcient,
perhaps even to the extent that there is a preferential formation
of wild-type-only multimers, or that heteromultimers form that
are, for example, less processive or that are defective in the
coupling of nucleotide hydrolysis with DNA unwinding. It is
again important to note here that the nucleotide binding and
hydrolysis pocket of ring helicases is formed at the interface
of subunits (see 32, for a review). Any disturbance by
mutation, however subtle, could be anticipated to affect the
hydrolysis cycle and its mechanistic coupling to DNA unwind-
ing, thus resulting in a less-effective enzyme.
Helicase activity and DNA binding
As described earlier, Twinkle has afﬁnity both to single-
stranded and double-stranded DNA (30). We measured the
afﬁnity of puriﬁed protein to a single-stranded DNA substrate
and found reduced binding for the mutations K319E, dup352–
364 and W315L, in agreement with their reduced helicase
activity (all three) and hexamerization (K319E and dup352–
364). Surprisingly, in our hands the S369P variant had a
clearly increased afﬁnity to ssDNA in contrast to the results
of Korhonen et al. (29), who reported a decreased binding
afﬁnity for the same variant. As we found an increased
amount of mtDNA nucleoids in cells expressing this variant
in contrast to other variants showing less nucleoids, the tight
binding of S369P Twinkle to mtDNA might inﬂuence the seg-
regation of nucleoids. The observed differences in binding
activity compared with Korhonen et al. could be explained
as described above for hexamerization. The unwinding
ability of all mutations in vitro was diminished compared
with wild-type Twinkle. Depending on the oligonucleotide
used as energy source the range of residual activity ranged
from ,10 to 76% remaining activity, but all mutations had
,55% maximal activity with UTP.
mtDNA replication in human cells expressing
Twinkle mutants and in Deletor mice
As all available in vitro assays for Twinkle function have the
disadvantage of working with a relatively inactive enzyme, we
studied the effect of adPEO variants on mtDNA replication
directly under physiological conditions. When expressed
approximately in a one-to-one ratio with wild-type Twinkle,
the ‘strong’ mutations showed a slowing-down of mtDNA
replication rate and an accumulation of replication intermedi-
ates (not shown). Under these conditions, comparable to the
situation in patients, mtDNA depletion is not detected, indicat-
ing that the slow replication is still sufﬁcient to keep mtDNA
copy-numbers normal. When mutant levels are increased, the
stalling is increased and results in reduced mtDNA levels. This
might explain why only the relatively mild A359T mutation
has been seen as homozygous in patients: a severely deleter-
ious Twinkle variant would lead to mtDNA loss already
early in the development. We used the exaggerated situation
of a mutant to wild-type ratio of ca. 4:1 (22) to study the
immediate effect on the replication machinery in detail. All
mutations localized in or close to the linker domain, except
for the A359T, caused relatively severe replication stalling
over the whole length of mtDNA. The observed stalling/
pausing phenotypes with most of the adPEO Twinkle
mutants are entirely consistent with our previous analysis of
catalytic and structural mutations in the Twinkle protein
(22); all of the Twinkle mutants except for the W474C
mutant (see later) showed more or less severe accumulation
of what we previously showed to be mostly double-stranded
DNA bubble and y-shaped replication intermediates,
while at the same time there was a strong reduction in the
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wild-type Twinkle, even at full induction, did not substantially
modify the types of replication intermediates observed, such
as RITOLS, though there did appear to be a small increase
in y-shaped replication intermediates (for a more extensive
comparison of the effects of wild-type and mutant proteins
on replication intermediates, we have also included a Sup-
plementary Material, Fig. S3 comparing effects at different
levels of induction). It should be pointed out again here that
overexpression of all mutants resulted in a more or less
severe drop in mtDNA levels, while no such drop was
observed for the wild-type protein even at full induction. For
a discussion of the implications of the stalling/pausing pheno-
type of Twinkle mutants with reference to the mechanisms of
mtDNA replication we refer to our previous paper (22). The
W474C mutation localized in the helicase domain of
Twinkle showed a slightly different effect on replication.
The stalling effect was limited to the non-coding region,
while replication in other parts of the mtDNA seemed to be
normal (not shown). Analysis of an OH-containing fragment
showed that only y-shaped replication intermediates accumu-
lated, while bubble intermediates, indicative of replication
initiation, were reduced or absent. This suggests a speciﬁc
effect of this mutation on the initiation in the non-coding
region of mtDNA, while elongation elsewhere seemed to be
less affected.
Analysis of various tissues of six-week-old Deletor mice
showed strong accumulation of replication intermediates com-
pared with non-transgenic littermates. This was a surprising
ﬁnding, since multiple mtDNA deletions are only detectable
in animals older than approximately nine months of age
(26), thus suggesting that perhaps the critical events that in
later live result in the typical molecular phenotype of PEO
occur at a much earlier age when mtDNA replication is still
frequent. Similarly, depletion of brain mtDNA is apparent in
older mice (26) but not in the 6-week-old animals, yet replica-
tion intermediates clearly accumulated at this stage already.
Finally, multiple mtDNA deletions accumulate in muscle,
heart and brain but not in liver and kidney (26 and unpublished
data), yet 6-week-old kidney also showed clear signs of repli-
cation stalling similar to what was observed in brain. These
differences could be explained by variable degrees of self-
regenerating capacity or apoptosis resistance of the various
tissues, but remain still to be clariﬁed.
Transcription
The expression of Twinkle mutations in human cells impaired
not only replication, but also the transcription of mtDNA.
Already after 2 days of expression the steady-state levels of
H-strand transcripts were depleted, an effect that clearly pre-
ceded the depletion of mtDNA. The impairment of RNA syn-
thesis might be due to several mechanisms. Firstly, as
replication is severely slowed down, an increasing number
of mtDNA molecules are in the state of replication. The
increased presence of replisomes on the mtDNA could cause
a collision of replication and transcription machineries and
abort successful transcription. Secondly, a change in mtDNA
topology was observed upon the expression of mutant
Twinkle. The proportion of relaxed molecules increased,
while supercoiled mtDNA molecules were less abundant
(unpublished data). At this point, however, the exact cause
and effect relationship is unclear. It remains to be determined
whether in adPEO patients a defect in the mitochondrial tran-
scription precedes the accumulation of multiple deletions and
could in fact contribute to the pathophysiology of adPEO by
inducing an oxidative phosphorylation deﬁciency.
Can we understand the functional consequences
of replication stalling in proliferating cells
versus post-mitotic tissues?
In proliferating cells mtDNA replication needs to keep pace
with the mitochondrial and cellular proliferation rate. Thus,
if mtDNA replication signiﬁcantly pauses or stalls without
immediately affecting cell proliferation one can expect a
drop in mtDNA copy-number and this is exactly what is
observed when we overexpress Twinkle mutants (this study
and 22), POLG1 mutants (22) and, for example, wild-type
TFAM (33) or when we knock-down Twinkle expression
(20). It is unclear at the moment what happens with stalled
replication forks during cell division, but expression of
Twinkle PEO mutants in cultured cells does not seem to
result in mtDNA deletions (none could be detected, neither
by Southern blot analysis nor by long range PCR, unpublished
data), which is in line with our previous observations with cul-
tured adPEO patient cells (unpublished data). One might
expect that a failure to complete replication would result in
a failure to divide nucleoids resulting in enlarged nucleoid
structures and a mosaic cell distribution of nucleoids. This is
indeed one of the phenotypes of some of our Twinkle variants
in cell culture. In contrast, in post-mitotic tissues the situation
is different as mtDNA replication is no longer coupled to the
cell cycle. Presumably in this case it is the balance between
mitochondrial (DNA) turnover and replication that determines
whether there will be a net loss of mtDNA copy-number. How
this different requirement for mtDNA replication might cause
multiple deletions to accumulate remains a matter of specu-
lation but we can envisage several scenarios. First, the persist-
ent presence of stalled/paused replication forks could elicit an
mtDNA repair response similar to SOS responses resulting in
the recruitment of speciﬁc repair proteins. We recently dis-
cussed a scenario of how enhanced rates of mtDNA repair
could result in enhanced rates of deletion formation (34). A
second scenario that cannot be excluded at this point would
be frequent focal depletion of mtDNA followed by reampliﬁ-
cation. Especially in a situation where replication is frequently
paused due to a partially defective replication machinery, this
could favour the ampliﬁcation of mtDNA deletions that natu-
rally occur at low frequencies. Finally, and in line with the
previous suggestion, replication stalling might induce an
increased rate of mitochondrial (DNA) turnover, for
example, via mitophagy (see also 26), combined with an
increased rate of replication in order to maintain normal
mtDNA steady-state levels. The observation that replication
intermediates abnormally accumulate in tissues of young
mice but multiple deletions and depletion are only observed
in much older animals could suggest that one or several mech-
anisms to efﬁciently deal with mtDNA replication problems
are in place and that the later onset mtDNA defects are a
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repair mechanisms. We are currently pursuing the various
possibilities suggested here.
MATERIALS AND METHODS
Cloning of expression constructs
The full-length cDNA of Twinkle variants were originally
cloned in the pcDNA3.1(-)/Myc-His A (Invitrogen), as pre-
viously described (18,35). All constructs were re-cloned in
the pcDNA5/FRT/TO vector (Invitrogen) taking advantage
of two PmeI restriction sites ﬂanking the multiple cloning
sites of the original pcDNA3 vector and the target vector.
The resulting fusion proteins contained the sequence of the
respective proteins followed by an Myc-His tag. All resulting
plasmid constructs were conﬁrmed by DNA sequencing.
Creation and maintenance of stable transfected
inducible expression cell lines
Stable cell lines expressing various Twinkle mutants upon
induction were created as described (22) using the Flp-InTM
T-RexTM 293 host cell line (Invitrogen), an HEK293 variant
containing a Flip recombination site at a transcriptionally
active locus. The resulting cells were grown in DMEM
medium (Sigma) supplemented with 10% FCS (Sigma),
1m ML -glutamine, 50 mg/ml uridine (Sigma), 150 mg/ml
Hygromycin and 15 mg/ml Blasticidin in a 378C incubator
at 8.5% CO2. To test cell lines for mosaic expression of
transgenes, which is a common problem with inducible cell
lines that are generated by allowing for random integration,
we routinely tested all cell lines using immunoﬂuorescence
(as described below). All cell lines tested in this manner
showed that .99% of cells were positive for expression and
that the protein was correctly localized in mitochondria.
Even at maximal induction levels there was no evidence of
mistargeting.
To induce expression the indicated amount of doxycycline
(DC) (Sigma) was added to the growth medium, and cells
were processed for further analyses. With longer than 2 day
induction, medium was refreshed every 2 days.
Mouse tissue collection
All animal procedures were performed according to protocols
approved by the ethical boards for animal experimentation of
the National Public Health Institute and Helsinki University
(agreement number STU575A/2004) and all experiments
were done in accordance with good practice of handling lab-
oratory animals and of genetically modiﬁed organisms. The
generation and the phenotypes of the Deletor and the wild-type
Twinkle overexpressor mice have been previously described
(20,26). The mice were housed in a humidity- and temperature-
controlled environment with free access to chow and water.
Mouse tissue samples were carefully dissected and immedi-
ately processed for DNA extraction.
Western blots
Cell lysates were prepared and analyzed for protein expression
by immunoblotting after SDS–PAGE (35). A primary mono-
clonal c-myc (Roche Molecular Biochemicals) antibody was
used for detection of recombinant proteins. Detection of
actin (polyclonal antibody from Novus Biologicals) was
used as a loading control. Peroxidase-coupled secondary anti-
body horse-anti-mouse or goat-anti-rabbit was obtained from
Vector Laboratories. Enhanced Chemiluminescence detection
was done essentially as described (35).
Southern blots
The mtDNA levels per cell and the conformation of mtDNA
were analyzed by one-dimensional agarose gels and Southern
blotting. Total DNA was extracted from cells by proteinase K
digest and Phenol–Chloroform extraction. mtDNA levels
were analyzed by separating 2 mgo fHindIII digested total
DNA on a 0.6% agarose gel in TBE. For conformational
studies, 1 mg of DNA was digested with BglII that does not
cut mtDNA, and separated over a 0.4% agarose gel in TBE
without ethidium bromide. All gels were blotted and hybri-
dized with
32P-labelled DNA probes containing the D-loop
region (nts 16341–151) or part of the cytochrome b sequence
(nts 14846–15357) of human mtDNA. The signal was quanti-
ﬁed by phosphorimager and for mtDNA copy-number deter-
mination normalized against the signal for 18S rDNA.
Northern blots
RNA for northern blot analysis was extracted with Trizol
(Sigma) using the manufacturer’s recommendations. 4 mgo f
total RNA per sample was run on a 1% agarose MOPS/formal-
dehyde gel, blotted and hybridized using standard techniques
(36). Blots were probed with ca. 500 bp double-stranded
DNA probes radioactively labelled by random-primed label-
ling. Exposures were performed using a phosphorimager
(Storm 840, Molecular Dynamics).
Quantitative PCR
The copy-number of mtDNA per cell was determined essen-
tially as described (22). Total cellular DNA was extracted
by Proteinase K digest and isopropanol precipitation, and
copy-numbers of cytochrome b (mtDNA) and APP (nuclear
DNA) were determined in a Taqman assay on an Abiprism
7000 (Applied Biosciences, Foster City, CA, USA) using plas-
mids containing the amplicons as standards.
Immunocytochemistry
Immunoﬂuorescent detection was done as described pre-
viously (37) using a monoclonal anti-DNA antibody
AC-30-10 (PROGEN, Shingle Springs, CA, USA) and a
monoclonal c-myc antibody (Roche Molecular Biochemicals)
as primary antibodies. Secondary antibodies were anti-mouse
IgG-Alexa-Fluor
w488 (Invitrogen, myc) and anti-mouse
IgM-Alexa Fluor
w568 (DNA). Image acquisition using confo-
cal microscopy was done as described (37).
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and oligomerization assays
In vitro assays for determination of helicase activities were
performed with highly enriched Twinkle preparations
derived from 293 Flp-InTM T-RExTM cells. Cells induced for
36 h were disrupted after short cytochalasin treatment (38);
mitochondria were isolated using differential centrifugation
and sucrose gradient puriﬁcation and then lyzed and sonicated
in high salt buffer (50 mM KH2PO4, pH 7.4, 1 M NaCl, 0.05%
Triton X-100, 10 mM Imidazol, 7 mM b-mercaptoethanol). The
lysate was incubated with TALON Co
2þ afﬁnity resin (Clon-
tech) for 1 h at 48C, the resin was washed twice each with high
and low salt buffer (25 mM Tris pH 7.6, 200 mM NaCl, 100 mM
L-arginine, pH 7.6, 40 mM Imidazol, 10% glycerol, 7 mM
b-mercaptoethanol) and His-tagged proteins binding to the
resin were isolated with elution buffer containing 25 mM
Tris pH 7.6, 200 mM NaCl, 100 mML -arginine, pH 7.6,
200 mM Imidazol, 50% glycerol. Protein extracts were ali-
quoted, shock frozen in liquid nitrogen and stored at –808C.
The concentration of Twinkle in the eluate was judged by
SDS–PAGE and Coomassie Brilliant blue staining using
BSA as a reference. Typically 100 mg mitochondrial wet
weight yielded 2–4 mg of Twinkle protein.
Helicase assays were performed as described (22) with a
radioactively end-labelled 60 nt oligonucleotide hybridized
to M13 (þ) ssDNA, forming a 20 nt double-stranded stretch
with a 40 nts 50 end overhang. The reaction conditions were
essentially as described previously (22), but the reaction mix
did not contain other DNA besides the substrate which was
used at a concentration of 3 fmol. UTP, ATP, GTP or
dGTP were added at 3 mM, if not indicated otherwise. Short-
term oligomerization of isolated Twinkle variants in vitro
was tested by crosslinking the protein with low concentrations
of glutaraldehyde followed by separation on an SDS–PAGE
and western blotting. Ca. 20 ng of Twinkle protein was
diluted in 20 ml of oligomerization buffer (25 mM Tris–HCl
pH 7.6, 100 mML -arginine, pH 7.6, 1 mM DTT, 10% glycerol)
containing either 50 mM NaCl (helicase conditions) or 400 mM
NaCl (high salt conditions). Glutaraldehyde measuring 0.02%
was added and the reaction mix incubated for 5 min at room
temperature. The crosslinking was stopped by adding 10 ml
of SDS-containing sample buffer and directly heat-denatured
for 10 min at 958C. The denatured sample was separated on
a 3–8% Tris–Acetate gel (NuPAGE, Invitrogen) and
Twinkle proteins were detected by regular western blotting.
The stability of Twinkle hexamers was analyzed by gel
ﬁltration. 100 ng of puriﬁed twinkle were separated over a
Sephadex 200 10/300GL column (GE healthcare) in high
salt buffer (25 mM Tris–HCl pH 7.6, 400 mM NaCl, 100 mM
L-arginine pH 7.6, 5 mM EDTA, 10% glycerol), proteins
from 0.5 ml fractions were precipitated with deoxycholate
and TCA and analyzed by western blot using the anti-myc
antibody.
Binding of Twinkle wild-type and mutant protein to a
ssDNA oligonucleotide was essentially performed as
described previously (30), but with the exception that we
used the following oligo nucleotide primer: CT TCC TGG
CTT GCT TTG GCT GAG CCA AAA in stead of an
oligodT primer; reactions were done in 20 ml with a protein
concentration of 50–100 ng as judged by Coomassie staining.
Binding was quantiﬁed by phosphorimaging and is expressed
as the level of binding relative to the wild-type protein.
Brewer-Fangman 2D neutral/neutral agarose
electrophoresis
Mitochondrial nucleic acids were extracted using cytochala-
sine (Sigma-Aldrich) as described (38). Puriﬁed mtDNA was
digested with HincII (human) or ClaI (mouse). The fragments
were separated by 2DNAGE as described (39,40) and the gels
were blotted and hybridized with a
32P-labelled DNA probe
for human mtDNA nts 14846–15357 or mouse mtDNA nts
16356–136.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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